Potential Benefits Drive Interest in Continuous Manufacturing
Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2014
Volume 2014 eBook
Issue 2
Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.
Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.
Download
Pharmaceutical Technology’s 2014 Bioprocessing and Sterile Manufacturing eBook.
Articles in this issue
Potential Benefits Drive Interest in Continuous Manufacturing
Continuous Bioprocessing Challenges
Determining Cross-Contamination Risks in Multiproduct Biopharmaceutical Facilities
Achieving and Maintaining Compliance Using Continuous Monitoring Systems
Optimizing the Sterilization of Liquids in Sealed Containers
Using Modular Systems in Biopharmaceutical Manufacturing
Determining Protein Oxidation Induced During Fill-Finish Operations
Single-Use Technology in Parenteral Fill/Finish
Recent Videos
Related Content
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024Podcast
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
